Related Experiment Video

Updated: Jul 18, 2026

Creating Rigidly Stabilized Fractures for Assessing Intramembranous Ossification, Distraction Osteogenesis, or Healing of Critical Sized Defects
07:35

Creating Rigidly Stabilized Fractures for Assessing Intramembranous Ossification, Distraction Osteogenesis, or Healing of Critical Sized Defects

Published on: April 11, 2012

Treatment of children with osteogenesis imperfecta

Frank Rauch1, Francis H Glorieux

  • 1Genetics Unit, Shriners Hospital for Children, 1529 Cedar Avenue, Montréal, Québec, Canada H3G 1A6.

Current Osteoporosis Reports
|November 23, 2006
PubMed

Insights

Bisphosphonate therapy can aid children with osteogenesis imperfecta (OI) by reducing pain and fractures. However, its optimal use and long-term effects require further study, especially for severe OI cases.

Area of Science:

  • Pediatric Orthopedics
  • Medical Genetics
  • Pharmacology

Background:

  • Osteogenesis imperfecta (OI) is a genetic disorder characterized by fragile bones.
  • Children with moderate to severe OI need comprehensive management including physiotherapy, rehabilitation, and surgery.
  • Bisphosphonates offer supportive treatment to enhance conventional therapies for OI.

Purpose of the Study:

  • To review the role of bisphosphonates in managing pediatric osteogenesis imperfecta.
  • To discuss the benefits and uncertainties surrounding bisphosphonate treatment in children with OI.
  • To provide guidance on the appropriate use of bisphosphonates in growing patients.

Main Methods:

  • Literature review focusing on bisphosphonate use in pediatric OI.
  • Analysis of existing studies on pamidronate, the most studied bisphosphonate.
  • Evaluation of clinical outcomes and long-term consequences.

Main Results:

  • Bisphosphonates can decrease pain, lower fracture incidence, and improve mobility in children with OI.
  • Intravenous pamidronate has the most available data, but optimal regimens and long-term effects are unknown.
  • Current evidence suggests reserving bisphosphonates for severe cases with significant clinical issues like fractures or deformities.

Conclusions:

  • Bisphosphonates are a valuable adjunct therapy for moderate to severe osteogenesis imperfecta in children.
  • Further research is needed to establish optimal treatment protocols and long-term safety profiles for bisphosphonates in pediatric OI.
  • Gene-based therapies are still in early preclinical development for OI treatment.

More Related Videos

A Rat Tibial Growth Plate Injury Model to Characterize Repair Mechanisms and Evaluate Growth Plate Regeneration Strategies06:53

A Rat Tibial Growth Plate Injury Model to Characterize Repair Mechanisms and Evaluate Growth Plate Regeneration Strategies

Published on: July 4, 2017

Related Concept Videos

Fractures: Bone Repair01:27

Fractures: Bone Repair

Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the procedure...
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Formation by Endochondral Ossification01:24

Bone Formation by Endochondral Ossification

Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...
Bone Remodeling and Repair01:31

Bone Remodeling and Repair

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...